Anticoagulants

You have accessRestricted access
Emergency Coagulation Assessment During Treatment With Direct Oral AnticoagulantsLimitations and Solutions
Matthias Ebner, Ingvild Birschmann, Andreas Peter, Florian Härtig, Charlotte Spencer, Joachim Kuhn, Gunnar Blumenstock, Christine S. Zuern, Ulf Ziemann and Sven Poli

Stroke. 2017;STROKEAHA.117.017981, originally published August 3, 2017
https://doi.org/10.1161/STROKEAHA.117.017981

Download PDF
You have accessRestricted access
Response by Barreto and Grotta to Letter Regarding Article, “Randomized, Multicenter Trial of ARTSS-2 (Argatroban With Recombinant Tissue Plasminogen Activator for Acute Stroke)”
Andrew D. Barreto and James C. Grotta

Stroke. 2017;STROKEAHA.117.018294, originally published July 28, 2017
https://doi.org/10.1161/STROKEAHA.117.018294

Download PDF
You have accessRestricted access
Geographic Variation in the Use of Oral Anticoagulation Therapy in Stroke Prevention in Atrial Fibrillation
Inmaculada Hernandez, Samir Saba and Yuting Zhang

Stroke. 2017;48:2289-2291, originally published June 27, 2017
https://doi.org/10.1161/STROKEAHA.117.017683

Download PDF
You have accessRestricted access
To Treat or Not to TreatAnticoagulants as Secondary Preventives to the Oldest Old With Atrial Fibrillation
Peter Appelros, Bahman Farahmand, Andreas Terént and Signild Åsberg

Stroke. 2017;48:1617-1623, originally published May 9, 2017
https://doi.org/10.1161/STROKEAHA.117.016902

Download PDF
You have accessRestricted access
Response by Pennlert et al to Letter Regarding Article, “Optimal Timing of Anticoagulant Treatment After Intracerebral Hemorrhage in Patients With Atrial Fibrillation”
Johanna Pennlert, Kjell Asplund and Marie Eriksson

Stroke. 2017;48:e116, originally published March 10, 2017
https://doi.org/10.1161/STROKEAHA.117.016838

Download PDF
You have accessRestricted access
Is There an Obesity Paradox for Outcomes in Atrial Fibrillation?A Systematic Review and Meta-Analysis of Non–Vitamin K Antagonist Oral Anticoagulant Trials
Marco Proietti, Elisa Guiducci, Paola Cheli and Gregory Y.H. Lip

Stroke. 2017;48:857-866, originally published March 6, 2017
https://doi.org/10.1161/STROKEAHA.116.015984

Download PDF CME
You have accessRestricted access
Automated Software System to Promote Anticoagulation and Reduce Stroke RiskCluster-Randomized Controlled Trial
Tim A. Holt, Andrew Dalton, Tom Marshall, Matthew Fay, Nadeem Qureshi, Susan Kirkpatrick, Jenny Hislop, Daniel Lasserson, Karen Kearley, Jill Mollison, Ly-Mee Yu, F.D. Richard Hobbs and David Fitzmaurice

Stroke. 2017;48:787-790, originally published January 24, 2017
https://doi.org/10.1161/STROKEAHA.116.015468

Download PDF
You have accessRestricted access
Optimal Timing of Anticoagulant Treatment After Intracerebral Hemorrhage in Patients With Atrial Fibrillation
Johanna Pennlert, Rosanna Overholser, Kjell Asplund, Bo Carlberg, Bart Van Rompaye, Per-Gunnar Wiklund and Marie Eriksson

Stroke. 2017;48:314-320, originally published December 20, 2016
https://doi.org/10.1161/STROKEAHA.116.014643

Download PDF CME
You have accessRestricted access
Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular EventsFindings From ENGAGE AF-TIMI 48 (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48)
Natalia S. Rost, Robert P. Giugliano, Christian T. Ruff, Sabina A. Murphy, Andrea E. Crompton, Andrew D. Norden, Scott Silverman, Aneesh B. Singhal, José C. Nicolau, Bhupathi SomaRaju, Michele F. Mercuri, Elliott M. Antman and Eugene Braunwald on behalf of the ENGAGE AF-TIMI 48 Investigators

Stroke. 2016;47:2075-2082, originally published July 7, 2016
https://doi.org/10.1161/STROKEAHA.116.013540

Download PDF CME
You have accessRestricted access
Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart FailureData From the Warfarin Versus Aspirin in Reduced Ejection Fraction Trial
Marco R. Di Tullio, Min Qian, John L.P. Thompson, Arthur J. Labovitz, Douglas L. Mann, Ralph L. Sacco, Patrick M. Pullicino, Ronald S. Freudenberger, John R. Teerlink, Susan Graham, Gregory Y.H. Lip, Bruce Levin, J.P. Mohr, Richard Buchsbaum, Conrado J. Estol, Dirk J. Lok, Piotr Ponikowski, Stefan D. Anker and Shunichi Homma for the WARCEF Investigators

Stroke. 2016;47:2031-2037, originally published June 28, 2016
https://doi.org/10.1161/STROKEAHA.116.013679

Download PDF

Header Publisher Menu

Stroke

Anticoagulants

Pages

Current Issue

Search This Journal

Related Collections

Customer Service

About Us

Our Sites

Take Action

Online Communities